26 June 2020: Original Paper
Should Pre-Transplant Hemoglobin A Be Used to Predict Post-Transplant Compliance in End-Stage Renal Disease Patients Undergoing Kidney Transplantation?
Samantha L. Terranella ABDEF , Jennifer Poirier ACDE , Edie Y. Chan ADE , Martin Hertl ADE , Oyedolamu K. Olaitan ABCDEF*DOI: 10.12659/AOT.924061
Ann Transplant 2020; 25:e924061
Table 3 Outcome measures by HbA1c Level.
| HbA1c ≤7.7% (135 patients) | HbA1c >7.7% (30 patients) | p-Value | |
|---|---|---|---|
| Documented noncompliance | 0.40 | ||
| Yes | 35 (25.9%) | 5 (16.7%) | |
| No | 100 (74.1%) | 25 (83.3%) | |
| Failed graft | 0.20 | ||
| Yes | 30 (22.2%) | 4 (13.3%) | |
| No | 105 (77.8%) | 26 (86.7%) | |
| Rejection episodes | 0.30 | ||
| Yes | 20 (14.8%) | 2 (6.7%) | |
| No | 115 (85.2%) | 28 (93.3%) | |
| Low immunosuppressant level | 0.30 | ||
| Yes | 63 (46.7%) | 18 (60.0%) | |
| No | 72 (53.3%) | 12 (40.0%) | |
| Data presented as count (percentage). | |||